Vical Incorporated (NASDAQ: VICL) is focused on researching and developing biopharmaceutical products designed to prevent and treat serious or life-threatening diseases. Possible applications of the company’s DNA delivery technology include DNA vaccines for infectious diseases or cancer, cancer immunotherapeutics, and cardiovascular therapies. By strategically partnering with other pharmaceutical companies and biotechnology companies, the company hopes to expand its product pipeline. For further information, visit the Company’s web site at www.vical.com.
- 18 years ago
QualityStocks
Vical Incorporated (NASDAQ: VICL)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection
HeartBeam (NASDAQ: BEAT) is developing technology aimed at improving how cardiac conditions are identified and monitored,…
-
QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Advancing Multi-Pronged Growth Strategy Across Beacon Mill and Swanson Gold Project
Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising. LaFleur…
-
QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) and Department of Commerce Sign Letter of Intent for $100 Million in CHIPS and Science Act Funding to Accelerate U.S. Leadership in Quantum Computing
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), the only dual-platform quantum computing company providing both annealing…